HekaBio is a pre-commercial company made up of a diverse group of healthcare experts. As a healthcare investment, development, and commercialization platform, HekaBio focuses on in-licensing and investing in leading global innovations. With an initial emphasis on oncology and radiation therapy, they successfully accelerate the commercialization process.

HekaBio is dedicated to empowering patients by providing accelerated access to breakthrough diagnostic, interventional, and medical innovations in Cardiology, Neurology, Oncology, and Ophthalmology. Their mission is to enable patients to benefit from global healthcare innovations. The brand's name, Heka, is derived from Egyptian mythology, where it represents healing and magic.

It signifies engaging the spirit or vital force. HekaBio upholds the core values of collaboration, maintaining strong relationships based on common goals, mutual respect, open communication, trust, and teamwork. They approach opportunities with creativity and deliver inspired solutions.

At HekaBio, they are committed, proactive self-starters who take accountability for achieving results